Catalyst Wire Dossier Catalyst Wire Dossier

Mevalotin

· Daiichi Sankyo
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mevalotin, covering 2025-07-23 to 2025-07-23. Get the full timeline:

Most recent: Clinical Trial Update: An Observational Study Investigating the Change in Blood Cholesterol With Mevalotin® Tablet Administration in Korean Menopausal Women Aged 50 Years or More Who Require Treatment of Dyslipidemia

See pricing